Mometasone furoate detailed information
Jump to navigation
Jump to search
 | |
| Clinical data | |
|---|---|
| Routes of administration | topical, nasal |
| ATC code | |
| Pharmacokinetic data | |
| Bioavailability | Nasal spray is virtually undetectable in plasma |
| Protein binding | 98% to 99% |
| Metabolism | hepatic |
| Elimination half-life | 5.8 hours |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| DrugBank | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C22H28Cl2O4 for Mometasone C27H30O6Cl2 as Furoate |
| Molar mass | 427.361 g/mol |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Mometasone furoate (also referred to as Mometasone) is a moderately potent glucocorticoid steroid used in the treatment of inflammatory skin disorders (such as eczema and psoriasis), allergic rhinitis (such as hay fever), and asthma for patients unresponsive to less potent corticosteroids. In terms of steroid strength, it is more potent than hydrocortisone, and less potent than dexamethasone.
Schering-Plough markets the medication under the following brand names; Elocon (Elocom) as a cream or ointment for skin conditions, Nasonex as a nasal spray for upper respiratory conditions, Asmanex Twisthaler as a dry powder inhaler (DPI) for lower respiratory conditions.
External links
Categories:
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Glucocorticoids
- Asthma
- Pulmonology